Skip to Main Content

Paper Details

Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.
Sci Transl Med
2
2023
Author NameAffiliation
Laurence Brugi??resGustave Roussy Cancer Center, Paris-Saclay University
Giorgio InghiramiCornell University
David M WeinstockDana Farber Cancer Institute
David M WeinstockHarvard Medical School
  • 1 - 4

Datasets

Release 1.2